Literature DB >> 32537152

The use of high dose topical capsaicin in the management of peripheral neuropathy: narrative review and local experience.

Sarah E Thomas1, Helen Laycock2.   

Abstract

Capsaicin, derived from the chilli pepper plant, is available in high concentration (8%) patches to provide topical therapy for neuropathic pain. Its analgesic effects relate to defunctionalisation and nerve terminal retraction of predominantly C fibres in the dermis and epidermis. Systematic reviews and meta-analysis support its use for the management of post-herpetic neuralgia and HIV neuropathy with some evidence for use in painful peripheral diabetic neuropathy. The article concludes with advice on the practicalities of running a topical 8% capsaicin clinic for peripheral neuropathic pain. © The British Pain Society 2020.

Entities:  

Keywords:  Neuropathic pain; capsaicin

Year:  2020        PMID: 32537152      PMCID: PMC7265596          DOI: 10.1177/2049463720914332

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  26 in total

Review 1.  Vanilloid (Capsaicin) receptors and mechanisms.

Authors:  A Szallasi; P M Blumberg
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

Review 2.  Transient receptor potential channels in pain and inflammation: therapeutic opportunities.

Authors:  Mark A Schumacher
Journal:  Pain Pract       Date:  2010-03-02       Impact factor: 3.183

3.  A new definition of neuropathic pain.

Authors:  Troels S Jensen; Ralf Baron; Maija Haanpää; Eija Kalso; John D Loeser; Andrew S C Rice; Rolf-Detlef Treede
Journal:  Pain       Date:  2011-07-18       Impact factor: 6.961

4.  Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  David M Simpson; Jessica Robinson-Papp; Joanna Van; Malcolm Stoker; Hélène Jacobs; Robert J Snijder; Diederik S Schregardus; Stephen K Long; Bruno Lambourg; Nathaniel Katz
Journal:  J Pain       Date:  2016-10-13       Impact factor: 5.820

5.  QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.

Authors:  Michel Lantéri-Minet; Serge Perrot
Journal:  Curr Med Res Opin       Date:  2019-01-07       Impact factor: 2.580

Review 6.  Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

7.  High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.

Authors:  Iwona Filipczak-Bryniarska; Roger M Krzyzewski; Jakub Kucharz; Anna Michalowska-Kaczmarczyk; Justyna Kleja; Jarosław Woron; Katarzyna Strzepek; Lucyna Kazior; Jerzy Wordliczek; Tomasz Grodzicki; Krzysztof Krzemieniecki
Journal:  Med Oncol       Date:  2017-08-17       Impact factor: 3.064

Review 8.  Capsaicin, Nociception and Pain.

Authors:  Bárbara Frias; Adalberto Merighi
Journal:  Molecules       Date:  2016-06-18       Impact factor: 4.411

9.  Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.

Authors:  Colette Mankowski; Chris D Poole; Etienne Ernault; Roger Thomas; Ellen Berni; Craig J Currie; Cecil Treadwell; José I Calvo; Christina Plastira; Eirini Zafeiropoulou; Isaac Odeyemi
Journal:  BMC Neurol       Date:  2017-04-21       Impact factor: 2.474

10.  Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.

Authors:  G Cruccu; T J Nurmikko; E Ernault; F K Riaz; W T McBride; M Haanpää
Journal:  Eur J Pain       Date:  2017-12-01       Impact factor: 3.931

View more
  1 in total

Review 1.  Scoping Review of Off-Label Topical Analgesia in Palliative, Hospice and Cancer Care: Towards Flexibility in Evidence-Based Medicine.

Authors:  Baraa O Tayeb; Jennifer A Winegarden; Rawabi A Alashari; Moudi Alasmari; Jonathan Winegarden; Faisal Boker; Abdulaziz Halawi; Amy Lapidow; Ylisabyth S Bradshaw; Daniel B Carr
Journal:  J Pain Res       Date:  2021-09-22       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.